KN
Keay Nakae Chardan Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Korro Bio
KRRO
$312M
| $33.18 | $25 |
25%
downside
| Buy | 24 days ago |
|
2
Monopar Therapeutics
MNPR
$273M
| $44.21 | $60 |
36%
upside
| Buy | 24 days ago |
|
3
Arrowhead Research
ARWR
$4.02B
| $29.07 | $60 |
106%
upside
| Buy | 27 days ago |
|
4
Arbutus Biopharma
ABUS
$805M
| $4.20 | $5 |
19%
upside
| Buy | 27 days ago |
|
5
ProQR Therapeutics
PRQR
$258M
| $2.45 | $4 |
63%
upside
| Buy | 1 month ago |
|
6
Avidity Biosciences
RNA
$6.48B
| $50.36 | $75 |
49%
upside
| Buy | 1 month ago |
|
|
SLN
7
Silence Therapeutics
SLN
$269M
| $5.69 | $35 |
515%
upside
| Buy | 1 month ago |
|
8
Alnylam Pharmaceuticals
ALNY
$59.2B
| $452 | $400 |
12%
downside
| Buy | 1 month ago |
|
9
Dyne Therapeutics
DYN
$2.02B
| $14.22 | $38 |
167%
upside
| Buy | 1 month ago |
|
|
MESO
10
Mesoblast
MESO
$1.84B
| $14.39 | $6 |
58%
downside
| Sell | 2 years ago |
|
11
Emergent Biosolutions
EBS
$404M
| $7.58 | $55 |
626%
upside
| Buy | 2 years ago |
|
12
Ocugen
OCGN
$322M
| $1.03 | $13 |
1,162%
upside
| Neutral | 4 years ago |
|